Parkside Financial Bank & Trust increased its position in CorVel Corp. (NASDAQ:CRVL – Free Report) by 8,769.0% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 2,572 shares of the business services provider’s stock after purchasing an additional 2,543 shares during the quarter. Parkside Financial Bank & Trust’s holdings in CorVel were worth $264,000 as of its most recent SEC filing.
Several other hedge funds have also bought and sold shares of the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. bought a new position in CorVel during the second quarter worth about $37,000. Bank of New York Mellon Corp lifted its position in shares of CorVel by 2.3% in the second quarter. Bank of New York Mellon Corp now owns 176,927 shares of the business services provider’s stock valued at $18,185,000 after buying an additional 4,001 shares during the last quarter. Versor Investments LP boosted its stake in shares of CorVel by 6.5% during the 2nd quarter. Versor Investments LP now owns 4,472 shares of the business services provider’s stock worth $460,000 after acquiring an additional 272 shares during the period. Strs Ohio increased its holdings in shares of CorVel by 7.6% during the 2nd quarter. Strs Ohio now owns 9,900 shares of the business services provider’s stock worth $1,018,000 after acquiring an additional 700 shares during the last quarter. Finally, Atria Investments Inc raised its stake in CorVel by 1.3% in the 2nd quarter. Atria Investments Inc now owns 14,646 shares of the business services provider’s stock valued at $1,505,000 after acquiring an additional 186 shares during the period. 51.36% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
CRVL has been the subject of a number of research analyst reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of CorVel in a research report on Tuesday, October 14th. Wall Street Zen cut shares of CorVel from a “buy” rating to a “hold” rating in a research note on Saturday. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, CorVel presently has an average rating of “Hold”.
CorVel Price Performance
Shares of NASDAQ CRVL opened at $75.97 on Monday. The firm has a market cap of $3.90 billion, a price-to-earnings ratio of 39.16 and a beta of 0.98. The stock’s fifty day moving average price is $78.01 and its two-hundred day moving average price is $92.97. CorVel Corp. has a one year low of $70.47 and a one year high of $128.61.
CorVel (NASDAQ:CRVL – Get Free Report) last announced its earnings results on Tuesday, November 4th. The business services provider reported $0.54 earnings per share (EPS) for the quarter. CorVel had a net margin of 10.98% and a return on equity of 32.31%. The company had revenue of $239.64 million during the quarter.
Insider Transactions at CorVel
In other news, CFO Brandon O’brien sold 1,764 shares of CorVel stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $91.54, for a total value of $161,476.56. Following the completion of the sale, the chief financial officer directly owned 8,948 shares in the company, valued at approximately $819,099.92. The trade was a 16.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Maxim Shishin sold 12,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $89.16, for a total value of $1,069,920.00. Following the completion of the sale, the insider owned 7,050 shares of the company’s stock, valued at approximately $628,578. This trade represents a 62.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 44.56% of the company’s stock.
CorVel Profile
CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
Further Reading
- Five stocks we like better than CorVel
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 3 Big Earnings Misses: Is It Time to Buy the Dip?
- What is a Stock Market Index and How Do You Use Them?
- Is Robinhood’s 11% Post-Earnings Fall a Buy-the-Dip Opportunity?
- What is the Shanghai Stock Exchange Composite Index?
- AI Demand Is Coming—Is Microchip Technology Ready?
Want to see what other hedge funds are holding CRVL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CorVel Corp. (NASDAQ:CRVL – Free Report).
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.
